Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 189, Supplement 653
The 86th Annual Meeting of The German Physiological Society
3/25/2007-3/28/2007
Hannover, Germany


THERAPY WITH ETANERCEPT AND INFLIXIMAB REDUCES THE MIGRATION OF ED1 POSITIVE CELLS INTO DRGS OF ARTHRITIC RATS
Abstract number: P21-L2-12

Segond von Banchet1 G, Bottger1 M, Brauer1 R, Schaible1 HG

1Institute of Physiology I, University of Jena

Studies in rats have demonstrated that nerve injury induces a migration of macrophages into the DRGs. Because TNFa plays a key role in maturation of macrophages we investigated whether the occurrence of ED1 positive cells changes in sections of DRGs

(L1-L5) during antigen-induced arthritis (AIA) of one knee joint of the rat with and without therapy (post-treatment) of the rats with etanercept or infliximab. For control application of NaCl was used. DRGs (L1-L5) from both sites were removed from normal rats and from rats at 0 and 3 (each n=5 rats) days after induction of AIA. The ganglia were fixed, embedded, cut into sections and incubated with an anti-ED1 antibody. Using a computer based analysing system we analysed changes in the grey value of a 5 mm2 area in each DRG sections. Only very few ED1 positive cells were found in ganglia from normal rats. But the presence of ED1 positive cells in the DRGs of both sides was increased significantly in the ganglia 3 days after induction of AIA. Both after therapy with etanercept and infliximab the presence of ED1 positive cells was significantly reduced. We conclude that inflammation of a knee joint induces an activation of macrophages not only at the site of inflammation but also in the ganglia. TNFa appears to be one of the essential factors for the migration of ED1 positive cells into the ganglia.

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 189, Supplement 653 :P21-L2-12

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE